MECHANISMS OF LUNG ALLOGRAFT ACCEPTANCE
MECHANISMS OF LUNG ALLOGRAFT ACCEPTANCE
批准号:
8530273
负责人:
ALEXANDER S. KRUPNICK
金额:
$36.18万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-15 至 2016-05-31
关键词:
Adverse effectsAlloantigenAllogenicAntigen-Presenting CellsApplications GrantsAutoimmune ProcessBacterial InfectionsCD28 geneCD4 Positive T LymphocytesCD8B1 geneCellsClinicClinicalClinical TrialsDataDevelopmentEnzymesEssential Amino AcidsFDA approvedGenerationsGoalsGraft RejectionGraft SurvivalHematopoieticHumanImmuneImmunologicsImmunosuppressionImmunosuppressive AgentsIn VitroInflammatoryInflammatory ResponseInterferonsKidneyLaboratoriesLeukocytesLifeLigandsLungLung TransplantationMHC Class I GenesMHC Class II GenesMediatingMicroscopyModelingMusOrganOrgan TransplantationOutcomePathway interactionsPatientsPerioperativePlayPredispositionPrimatesProcessPropertyProtocols documentationRegulatory T-LymphocyteReperfusion InjuryReportingRodent ModelRoleSecondary toSignal TransductionSolidSourceSystemT-Cell ActivationT-LymphocyteTNFRSF5 geneTNFSF5 geneTestingToll-Like Receptor 2Transplant RecipientsTransplantationUp-RegulationWorkallograft rejectionbaseclinically relevantexperiencegraft failureimmunogenicimmunogenicityimmunoregulationimprovedin vivolung allograftlung basal segmentpreventresearch studyresponsesuccesstwo-photon
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): It is well established that various organ allografts differ in their immunogenicity and susceptibility to immunosuppression-mediated acceptance. Lungs are among the most immunogenic organs with particularly high rates of graft rejection leading to poor long-term outcomes. Immunologic requirements for lung allograft rejection and acceptance remain poorly understood. Our laboratory has made the surprising observation that, in stark contrast to other organs, the presence of CD8+ (specifically CD8+PD-1+) rather than CD4+ T cells, is critical for co-stimulatory blockade-mediated acceptance of lung allografts. The overall goal of this application is to perform mechanistic studies in the mouse vascularized orthotopic lung transplantation model to investigate the role of CD8+ T cells in down-regulating alloimmune responses deleterious to graft survival. In the first aim we will define mechanisms of regulatory CD8+ T cell generation. In the second aim we will investigate the role of antigen presenting cells in CD8+ T cell-mediated lung allograft acceptance. In the third aim we will characterize how clinically relevant innate immune stimulation through Toll-like receptor 2 (TLR2) prevents CD8+ T cell-mediated lung allograft acceptance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inflammatory Cellular Mechanisms for Establishing and Maintaining Lung Allograft Tolerance
-
批准号:10024445
-
项目类别:
-
资助金额:$49.81万
-
财政年份:2015
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
Inflammatory Cellular Mechanisms for Establishing and Maintaining Lung Allograft Tolerance
-
批准号:10625537
-
项目类别:
-
资助金额:$44.95万
-
财政年份:2015
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
Inflammatory Cellular Mechanisms for Establishing and Maintaining Lung Allograft Tolerance
-
批准号:10197018
-
项目类别:
-
资助金额:$47.39万
-
财政年份:2015
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
Inflammatory Cellular Mechanisms for Establishing and Maintaining Lung Allograft Tolerance
-
批准号:10619068
-
项目类别:
-
资助金额:$45.46万
-
财政年份:2015
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
Mechanisms of Immunosurveillance for Lung Cancer-the Role of CD8+ T Cells in Tumor Tolerance Induction
-
批准号:10512744
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
Mechanisms of Immunosurveillance for Lung Cancer
-
批准号:9280818
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
Mechanisms of Immunosurveillance for Lung Cancer
-
批准号:8974355
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
Mechanisms of Immunosurveillance for Lung Cancer-the Role of CD8+ T Cells in Tumor Tolerance Induction
-
批准号:10255913
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
Mechanisms of Immunosurveillance for Lung Cancer
-
批准号:8629870
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
MECHANISMS OF LUNG ALLOGRAFT ACCEPTANCE
-
批准号:8847372
-
项目类别:
-
资助金额:$37.43万
-
财政年份:2012
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
MECHANISMS OF LUNG ALLOGRAFT ACCEPTANCE
-
批准号:8372581
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2012
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
MECHANISMS OF LUNG ALLOGRAFT ACCEPTANCE
-
批准号:8669146
-
项目类别:
-
资助金额:$37.24万
-
财政年份:2012
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
The Role of Non-Hematopoietic Cells in Tumor Tolerance Induction
-
批准号:7920564
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2009
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
The Role of Non-Hematopoietic Cells in Tumor Tolerance Induction
-
批准号:8116998
-
项目类别:
-
资助金额:$12.06万
-
财政年份:2008
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
The Role of Non-Hematopoietic Cells in Tumor Tolerance Induction
-
批准号:7686139
-
项目类别:
-
资助金额:$12.06万
-
财政年份:2008
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
The Role of Non-Hematopoietic Cells in Tumor Tolerance Induction
-
批准号:8323951
-
项目类别:
-
资助金额:$11.99万
-
财政年份:2008
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
The Role of Non-Hematopoietic Cells in Tumor Tolerance Induction
-
批准号:7906933
-
项目类别:
-
资助金额:$12.06万
-
财政年份:2008
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
The Role of Non-Hematopoietic Cells in Tumor Tolerance Induction
-
批准号:7356202
-
项目类别:
-
资助金额:$12.06万
-
财政年份:2008
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
TISSUE ENGINEERING FOR DIAPHRAGMATIC RECONSTRUCTION
-
批准号:6388740
-
项目类别:
-
资助金额:$4.56万
-
财政年份:2001
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
TISSUE ENGINEERING FOR DIAPHRAGMATIC RECONSTRUCTION
-
批准号:6183096
-
项目类别:
-
资助金额:$4.09万
-
财政年份:2000
-
负责人:ALEXANDER S. KRUPNICK
-
依托单位:
海外基金